Shenzhen Neptunus Interlong Bio-Technique Co Ltd

08329

Company Profile

  • Business description

    Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.

  • Contact

    979 King’s Road
    43rd Floor, One Taikoo Place
    Quarry Bay
    Hong Kong
    HKG

    https://www.interlong.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,382

Stocks News & Analysis

stocks

Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity

Ongoing rate hikes have investors spooked.
stocks

ASX dividend champions: Stocks, ETFs and LICs

Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
stocks

SpaceX’s IPO filing: Big spending, big losses

The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,862.5012.200.14%
CAC 408,117.42135.661.70%
DAX 4024,737.24336.591.38%
Dow JONES (US)50,009.35645.471.31%
FTSE 10010,432.34101.790.99%
HKSE25,764.99113.870.44%
NASDAQ26,270.36399.651.54%
Nikkei 22561,810.642,006.233.35%
NZX 50 Index12,833.1572.120.57%
S&P 5007,432.9779.361.08%
S&P/ASX 2008,641.2013.200.15%
SSE Composite Index4,186.0323.850.57%

Market Movers